logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Medical technology is not considered a huge-margin investment in the way that the biotech and drug industries are. However, some of today's medtech blurs the line, including hybrid companies developing stem cell and drug-device delivery systems that address complex disease indications ranging from blindness to spinal paralysis. Caroline Corner of…
Read more...
vTv Therapeutics  (VTVT) is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. The company is based in High Point, NC. Five other companies are scheduled to IPO for the week of July 27. The full IPO…
Read more...
Biotechnology stocks continue to outperform this year.  While SPDR S&P Biotech ETF (XBI) and several other biotech ETFs have produced strong returns this year and for the past several years, investors are also attracted to individual companies in the biotechnology industry, since choosing an individual winner can be very rewarding.…
Read more...
In the U.S., the medical device and diagnostics industry has been burdened with conflicting regulations that have delayed commercialization and complicated reimbursement. In this interview, Brian Marckx, senior medical device/diagnostics analyst with Zacks Investment Research, tells The Life Sciences Report how that situation is changing and identifies some innovative companies…
Read more...
BG Medicine, Inc. (BGMD) is a commercial stage company that engages in developing and commercializing diagnostic products used to guide patients suffering from heart failure and other disorders. They experienced a 58.45% increase in their share price today, increasing from $1.65 to $2.44. And while average volume has been thin,…
Read more...
Chiasma (CHMA) is a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection. The company is based in Newton, MA. Seven other companies are scheduled to IPO for the…
Read more...
BioCardia (BCDA) is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. It is based in San Carlos, CA, Seven other companies are scheduled to IPO for the week of July 13. The full IPO calendar is available at IPO Premium. SEC Documents…
Read more...
Eyegate Pharma (EYEG) is a thinly traded microcap stock with shares that exploded about two weeks ago, and experienced another 45% pop this morning as volume began to build a base. Volume has been so skinny I think it left many on the outside looking in, but today, on the…
Read more...
It's all about the fundamentals for Jason Napodano, CFA, of Zacks Investment Research. Revenue and earnings at the big biotechs are signaling investors that the market is still strong, and that there is still a huge thirst for early-stage devices, small molecules, biologics and cellular therapies. In this interview with…
Read more...
Over the first six months of 2015, the market has not performed very well. Since the 1st of the year, the DJIA has essentially remained the same (down 0.4% to be exact). The S&P 500 has also practically remained the same. The NASDAQ has had modest gains, but nothing exceptional.…
Read more...
Over the first six months of 2015, the market has not performed very well. Since the 1st of the year, the DJIA has essentially remained the same (down 0.4% to be exact). The S&P 500 has also remained practically unchanged. The NASDAQ has had modest gains, but nothing exceptional. But while…
Read more...
The life sciences industry is evolving rapidly. Many say it's at the beginning of an explosive growth stage that will see the development and commercialization of novel therapeutics and diagnostics still being imagined in scientific laboratories today. This explosion of innovation also means an explosion of investment opportunity. In this…
Read more...
Page 1 of 54
 Today's Must Reads

Beyond Twitter: 5 Small-Cap Tech Plays Nobody’s Talking About


Will the Fed Continue Its Track Record of Unprecedented Moves?

Facebook versus Google: Who Rules the Internet?

Are These the Worst Business Documentaries on Netflix?


Saving the

Small-Cap Market

 

Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN